ALFA Filings
Every announcement, straight from the exchange
Every Asston Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Asston Pharmaceuticals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. It also disclosed a recent preferential allotment of 24.10 lakh equity shares.
Asston Pharmaceuticals Limited announced a change in the company's registered office address within the same city, effective from 15th October 2026.
Asston Pharmaceuticals Limited has appointed M/s. Panchal S K & Associates as its Statutory Auditor for a five-year term. The appointment is effective from April 1, 2026.
Asston Pharmaceuticals Ltd submitted its quarterly shareholding pattern disclosure, detailing the shareholding status of promoters and public shareholders for the period ended March 2026.
Asston Pharmaceuticals Limited (BSE: 544445) declared the non-applicability of the Annual Secretarial Compliance Report under SEBI (LODR) Regulation 15(2). As an SME-listed entity, the company is exempt from certain corporate governance provisions. The company confirms it will continue to comply with all other applicable listing regulations.